amniotic membrane

Financial Conflicts of Interest in Studies Related to the Use of Placental Membrane Allografts

Introduction Determine accuracy of self-reporting of conflicts of interest (COI) among studies of placental membrane allograft products and evaluate factors associated with increased disc...

Tina Tian , MD;

Charlie Zaepfel , MS;

Joshua A. Bloom , MD;

Khaled Alnahhal , MD;

Abhishek Chatterjee , MD, MBA, FACS;

Mark Iafrati , MD;

Geneve Allison , MD, MSc;

Payam Salehi , MD, PhD;

08/19/2021

Case Report

Innovative Use of dHACM in Conjunction With Hyperbaric Oxygen Therapy to Treat a Nonhealing Nasal Wound Subsequent to Squamous Cell Carcinoma Resection and Radiation: A Case Study

03/25/2019

Shari S. Houle ;

Jessica A. Henderson ;

Mark W. Jones ;

Hyperbaric oxygen therapy is known to improve wound healing in the setting of chronic, nonhealing wounds of irradiated skin; however, failure of wound healing may still occur. Dehydrated human amnion/chorion membrane (dHACM) grafting is a...

Hyperbaric oxygen therapy is...

03/25/2019

Wounds

Case Series

Surgical Application of Viable Cryopreserved Placental Membrane for the Treatment of Chronic Wounds in 12 High-risk Patients

11/01/2018

Dorothy H. Kurtz Phelan ;

Walter D'Costa , DPM;

The objective of this retrospective case series is to evaluate the safety and efficacy of a viable cryopreserved placental membrane (vCPM) in 12 patients with 16 wounds of mixed etiologies when surgically debrided and augmented with vCPM 1...

The objective of this...

11/01/2018

Wounds

Clinical Research Poster

A Multicenter, Randomized, Single-blind Trial Comparing the Efficacy of Viable Cryopreserved Placental Membrane to Human Fibroblast-derived Dermal Substitute for the Treatment of Chronic Diabetic Foot Ulcers

10/16/2018

BACKGROUND: Randomized, controlled clinical trials (RCTs), the gold standard to determine treatment efficacy against a control, have demonstrated advantages of skin substitutes for the treatment of chronic diabetic foot ulcers (DFUs) in...

BACKGROUND: Randomized,...

10/16/2018

Wounds

Original Research

Open-label Extension Phase of a Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Using Cryopreserved Placental Membrane

09/01/2018

Matthew J. Regulski , DPM, ABMSP, CMET, FAPWH(c);

Lawrence A. Lavery , DPM, MPH;

James Fulmer ;

David Fried ;

Howard Kashefsky ;

Janaki Nadarajah ;

Dean Vayser , DPM, FACFAS;

Tammy M. Owings ;

Karry Ann Shebetka ;

Zoe Hesp ;

09/01/2018

Wounds

Case Series

Efficacy of Dehydrated Human Amniotic Membrane Allograft for the Treatment of Severe Extravasation Injuries in Preterm Neonates

08/01/2018

Colleen Galiczewski ;

Vita Boyar , MD, FAAP, WCPS, FABWH, FAPWCA;

This case series of 4 neonatal patients describes the experience and efficacy of using a dehydrated human amniotic membrane allograft (dHAMA) in the treatment of severe extravasation injuries.

This case series of 4 neonatal...

08/01/2018

Wounds

Feature

A Closer Look At The Role Of Amniotic Membrane For Diabetic Foot Ulcers

07/24/2018

Barry I. Rosenblum , DPM, FACFAS;

Christopher Sullivan , DPM;

Amniotic membrane is an increasingly utilized tool for physicians to spur healing in chronic diabetic foot ulcers. These authors take a closer look at the research and potential of both cryopreserved and dehydrated amniotic membrane. The...

Amniotic membrane is an...

07/24/2018

Podiatry Today

Case Series

Application of Viable Cryopreserved Human Placental Membrane Grafts in the Treatment of Wounds of Diverse Etiologies: A Case Series

02/28/2018

Ebony Love ;

Derek S. Anselmo , DPM;

James B. McGuire , DPM, PT, cPed, CWS, FAPWCA, FAPWHc;

02/28/2018

Wounds

Original Research